United Therapeutics Corp (NASDAQ:UTHR)

105.56
Delayed Data
As of May 23
 +0.48 / +0.46%
Today’s Change
100.57
Today|||52-Week Range
152.55
-28.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues444.6M445.5M464.7M389.2M
 
 
 
 
 
Cost of Goods Sold11.2M11.8M45.3M45.3M
 
 
 
 
 
Depreciation And Amortization7.7M7.7M7.7M7.9M
 
 
 
 
 
 
Operating ExpensesGross Income425.7M426.0M411.7M336.0M
 
 
 
 
 
General Expenses127.2M102.2M272.7M29.1M
 
 
 
 
 
Research And Development59.8M55.0M113.6M35.7M
 
 
 
 
 
Total Operating Expenses146.1M121.7M325.7M82.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income298.5M323.8M139.0M306.9M
 
 
 
 
 
Extraordinary Charge-256.5M-3.1M0.000.00
 
 
 
Interest Expense On Debt1.4M3.3M3.5M2.6M
 
 
 
 
 
Other Expenses3.6M3.3M5.5M4.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income44.2M320.7M141.0M309.0M
 
 
 
 
 
Income Taxes-100.2M-44.4M-122.0M-64.5M
 
 
 
 
 
Net Income-56.0M276.3M19.0M244.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.9M43.4M43.2M43.3M
 
 
 
 
 
Shares To Calculate EPS Diluted44.9M44.1M43.8M43.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.25$6.27$0.43$5.57
 
 
 
 
 
EPS Diluted-$1.25$6.27$0.43$5.57